Hayfever Vaccine UK 2026: NHS Grazax (SLIT) Eligibility and Private Costs Explained

Grazax sublingual immunotherapy tablets dissolve under the tongue daily for three years and remain the main NHS-funded grass pollen vaccine in the UK in 2026.

Every UK summer brings the same question from patients at the surgery: is there a hayfever vaccine? In 2026 the honest answer is yes, sort of — but it is not what most people picture when they hear the word vaccine.

What exists is a treatment called allergen immunotherapy. The version most commonly prescribed on the NHS for grass pollen allergy is a sublingual tablet called Grazax, taken daily under the tongue for three consecutive years. Its sister product, Acarizax, covers house-dust-mite allergy. There is also a birch-pollen option called Itulazax. You may have heard of the Kenalog injection, which was once offered privately as a single seasonal jab — it has been withdrawn from NHS use and is no longer recommended by the BSACI.

This article walks through who actually qualifies for Grazax on the NHS in 2026, how the referral pathway works, what private clinics charge, and what realistic results look like after a full course.

What people mean by hayfever vaccine in 2026

When patients ask about a hayfever vaccine, they usually mean one of three things: a single injection that stops symptoms for the summer, a tablet that retrains the immune system, or something they read about online that promises a permanent cure. The medical term for all of these is allergen immunotherapy, sometimes shortened to AIT or desensitisation. It works by exposing the immune system to small, repeated doses of a specific allergen — in this case grass pollen — so the body gradually becomes less reactive.

In the UK in 2026, two delivery routes exist. Sublingual immunotherapy, or SLIT, involves a daily tablet dissolved under the tongue. This is the method used by Grazax and is by far the more common grass-pollen approach in UK practice. Subcutaneous immunotherapy, or SCIT, involves regular injections given at a specialist clinic and is used for some allergies but is less frequently prescribed for hayfever here. Neither is a one-off jab. A full SLIT course runs daily for three years, because the immune system needs sustained exposure to change its long-term response.

You may still see the Kenalog injection advertised at private aesthetics clinics. Kenalog is triamcinolone acetonide, a depot steroid. It was withdrawn from NHS use for seasonal allergic rhinitis because of systemic steroid side effects — mood changes, blood sugar disturbance, adrenal suppression — and because it never had strong comparative-effectiveness data. The BSACI advises against it.

Separately, high-dose fexofenadine 180 mg daily has been reclassified for over-the-counter sale in UK pharmacies as of 2026, giving hayfever sufferers a stronger non-sedating antihistamine option without a prescription. This is symptom management, not immunotherapy, but it is worth knowing about before pursuing a specialist referral.

NHS eligibility for Grazax in 2026: the actual criteria

NHS funding for Grazax is not automatic. NICE supported sublingual grass-pollen immunotherapy through NICE TA246, and the BSACI has published position statements endorsing it for severe seasonal allergic rhinitis. But each Integrated Care Board sets its own local pathway, and in practice the eligibility bar is fairly high.

You will typically need all of the following:

The point about optimised treatment is important. An audit at Leeds Teaching Hospitals found that a significant proportion of patients referred for immunotherapy had never used their nasal steroid spray consistently or had been prescribed the wrong dose. Your GP will want to make sure the basics have been done properly before referring you. Some ICBs require a trial of montelukast before referral; others do not. The criteria are not identical across the country.

How the NHS referral pathway works

The process from GP appointment to first Grazax tablet is not quick, but it is straightforward once you know what to expect.

Step one: book a GP review. Describe your symptoms honestly, including how they affect work, sleep, and daily life. If you have not yet tried a regular nasal corticosteroid spray alongside an antihistamine for a full pollen season, your GP will likely start there and review you the following year.

Step two: once first-line treatment has been given a proper trial and has not worked, your GP refers you to a local allergy or clinical immunology service. In some areas this may sit within an ENT or respiratory department rather than a dedicated allergy clinic. Guy’s and St Thomas’ NHS Foundation Trust runs one of the largest allergy services in England, while regional centres in Bristol, Sheffield, and Newcastle also accept referrals.

Step three: the allergy clinic confirms the diagnosis with skin-prick or specific IgE testing and decides whether SLIT is appropriate. If yes, your first dose of Grazax is taken in the clinic under observation for at least 30 minutes, because there is a small risk of anaphylaxis on the very first dose.

Step four: once the clinic is satisfied you have tolerated the first dose safely, prescribing transfers to your GP under a shared-care agreement. You take the tablet daily at home for the rest of the three-year course. The allergy clinic reviews you annually.

The main practical obstacle is waiting time. NHS allergy clinic waits in 2026 range from around eight weeks in some areas to more than twelve months in others. If your local service has a long queue, your GP can check the BSACI directory for alternative clinics that accept out-of-area referrals.

Private SLIT costs in the UK in 2026: what you actually pay

If the NHS waiting list is too long, or your local ICB does not fund immunotherapy for your situation, private allergy clinics are an alternative — but the costs are real and the commitment is long.

A typical private pathway starts with an initial consultation and allergy testing, usually skin-prick testing to confirm grass-pollen sensitisation. In 2026, this costs around £250 to £350 at most UK private allergy clinics. If SLIT is recommended, Grazax costs roughly £3 per tablet at private dispensing rates. Over a year that comes to approximately £1,100. The course runs for three years, so the total medication cost alone is in the region of £3,300. Most private clinics include annual review appointments within the immunotherapy package, but check this before committing.

Subcutaneous immunotherapy — the injection-based alternative — typically costs £1,500 to £2,500 per allergen per year at central London clinics. For patients with multiple sensitivities this adds up quickly. If your primary allergy is house-dust mite rather than grass pollen, Acarizax follows a similar pricing structure.

You will still see the Kenalog injection advertised privately, often at aesthetics clinics, for around £80 to £150 per shot. It remains legal, but the BSACI does not recommend it, and NHS allergy specialists have raised concerns about clinics offering it without adequate allergy testing or follow-up.

Three years is non-negotiable if you want meaningful, lasting benefit. A single season of Grazax will not retrain your immune system. Before spending privately, make sure you are prepared for the full commitment.

What results to expect from a 3-year SLIT course

Managing expectations is one of the most useful things a GP can do before someone starts immunotherapy. SLIT is not a cure for hayfever. It is a treatment that meaningfully reduces symptom severity and the amount of medication you need through the pollen season.

In placebo-controlled trials, Grazax reduced rhinoconjunctivitis symptom scores by around 30 to 35 per cent and cut rescue medication use by approximately 35 to 40 per cent. In everyday terms, that means fewer days of streaming eyes and nose, less disruption to outdoor activities, and a reduced need for antihistamines and nasal sprays during peak season.

The effect builds gradually. Most patients notice some improvement during their first pollen season on Grazax, but the real benefit tends to come in years two and three. Stopping the course early — say after one year — gives substantially less benefit than completing the full three-year programme.

One of the more encouraging findings from longer follow-up studies is that the benefit persists for several years after treatment ends. Pooled trial data showed sustained symptom improvement up to two years after completing a three-year Grazax course. Some patients need a top-up course eventually, but for many the improvement holds well beyond the treatment period.

It helps to think of SLIT as a long-term investment rather than an instant fix. You will still need your nasal spray and antihistamines during the first summer, and possibly into the second. By the third season, a meaningful proportion of patients describe the change as significant — not because hayfever disappears, but because it becomes manageable enough to get through a British summer without it dominating every plan.

Who should not take Grazax

Grazax is a well-studied treatment, but it is not suitable for everyone. Your specialist will work through a checklist of contraindications and cautions before prescribing.

The most important exclusion is severe or uncontrolled asthma. If your FEV1 is below 70 per cent of predicted, or you have had a recent severe asthma exacerbation, SLIT is generally not started. The concern is that introducing a controlled allergen dose could trigger a more serious respiratory reaction in someone whose airways are already unstable. Eosinophilic oesophagitis is another firm exclusion, as SLIT can theoretically worsen it. Active autoimmune disease and current malignancy are also reasons to avoid starting treatment.

If you are pregnant or breastfeeding at the time of initiation, Grazax will not be started. However, if you become pregnant while already mid-course, most specialists advise continuing rather than stopping, since the risk of withdrawal may outweigh the risk of ongoing treatment. This is a decision for your prescribing specialist. Beta-blockers are a relative contraindication because they can reduce the effectiveness of adrenaline if emergency treatment for anaphylaxis is needed. Some specialist protocols also flag ACE inhibitors.

The most common side effects are local: itching or tingling under the tongue, mild swelling in the mouth, occasional ear itching, and sometimes mild stomach upset. A real-world UK audit reported that around 60 per cent of patients experienced some oral symptoms in the first few weeks, but most settled within a month. Anaphylaxis on the very first dose is rare — estimated at less than one in a thousand in pooled trial data — which is why that initial 30-minute clinic observation exists.

Practical alternatives if SLIT is not an option

For the majority of UK hayfever sufferers, immunotherapy is not necessary. Optimised first-line treatment controls symptoms well enough for most people, and it is worth making sure this is done properly before assuming you need a specialist referral.

The foundation is a daily intranasal corticosteroid spray, started one to two weeks before the pollen season and used every day through to the end. Mometasone, fluticasone, and budesonide are all available on NHS prescription. Many patients give up on nasal sprays because they try them for a few days and decide they do not work. The evidence is clear: used correctly and consistently, intranasal corticosteroids are the single most effective hayfever treatment available without seeing a specialist.

Add a non-sedating second-generation antihistamine. Cetirizine and loratadine are cheap and widely available. Fexofenadine 180 mg is now available over the counter in UK pharmacies, giving you a higher-potency option without a prescription. Eye symptoms respond to sodium cromoglicate or olopatadine eye drops. A saline nasal rinse such as Sterimar can help clear pollen from the nasal passages and improve the effectiveness of the corticosteroid spray. For selected patients whose hayfever overlaps with asthma symptoms, montelukast can be added on your GP’s advice.

Lifestyle measures make a measurable difference too. A UKHSA-supported review found that keeping windows closed on high pollen days, using pollen filters in cars, showering and changing clothes after being outdoors, and avoiding outdoor laundry drying during peak season all reduce pollen exposure meaningfully. These steps sound simple, but used together they make a noticeable difference to daily symptoms.

Frequently Asked Questions

Is the hayfever vaccine free on the NHS in 2026?

Yes, for patients who meet the eligibility criteria and are accepted by a local allergy or immunology service, Grazax is funded by the NHS. There is no prescription charge in Scotland, Wales, or Northern Ireland. In England, the standard NHS prescription charge applies per item unless you hold a medical exemption certificate or prepayment certificate. The initial allergy clinic consultation and testing are also NHS-funded when referred by your GP.

How long is the NHS waiting list for an allergy clinic referral?

This varies considerably by region. Some centres, including well-established services in London, Manchester, and Cambridge, can see referrals within eight to twelve weeks. Others, particularly areas relying on smaller ENT or respiratory-led shared services, may stretch beyond twelve months. If your local wait is long, ask your GP to check the BSACI directory of allergy clinics — some specialist centres accept out-of-area referrals, which can shorten the wait significantly.

Can I just buy Grazax privately without seeing an allergy specialist?

No. UK regulations require an initial consultation with a qualified allergy specialist, skin-prick or specific IgE testing to confirm grass-pollen sensitisation, and supervised first-dose administration with 30 minutes of observation. Reputable private clinics will not dispense Grazax without this process. Online-only prescriptions for immunotherapy products do not meet the standard of care the BSACI recommends, and most UK pharmacies will not fulfil them.

Does the Kenalog injection still exist in the UK?

Kenalog — triamcinolone acetonide — is still legally available, and some private aesthetics and wellness clinics continue to offer it as a hayfever injection, typically for £80 to £150. However, it was withdrawn from NHS use for seasonal allergic rhinitis because of systemic steroid side effects including mood disturbance, blood sugar changes, and adrenal suppression. The BSACI advises against its routine use. If you are offered it, ask what allergy testing and follow-up the clinic provides.

When should I start the 3-year course?

Guidelines recommend starting at least eight to sixteen weeks before the expected pollen season. For UK grass pollen, which typically peaks from late May to July, that means beginning your Grazax course between February and April. Starting earlier in that window gives the immune system more time to begin the desensitisation process before high pollen counts arrive. Your allergy specialist will advise on the optimal start date based on your specific pollen sensitivity.

Will my hayfever return after I finish 3 years of SLIT?

Most people retain a significant degree of benefit for several years after completing a full three-year Grazax course. Clinical follow-up data shows sustained symptom reduction at two years post-treatment. However, the effect is not lifelong for everyone. Some patients find that symptoms gradually return and need a repeat course. The majority, though, describe lasting improvement that makes summer notably more tolerable than it was before treatment began.

Is SLIT safe in children?

Grazax is licensed from age five and Acarizax from age twelve. Paediatric allergy services at trusts such as Guy’s and St Thomas’ and Leeds Teaching Hospitals regularly prescribe SLIT for children with severe hayfever. The safety profile in children is broadly similar to adults: local oral itching and swelling are common in the first few weeks, and the rare risk of anaphylaxis on the first dose means supervised initiation is essential. Many parents find the reduction in seasonal medication burden worth the early adjustment period.

This article is informational only and does not replace personalised advice from your GP, pharmacist, or another qualified healthcare professional.